Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWPP Regulatory News (WPP)

Share Price Information for WPP (WPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 847.40
Bid: 850.00
Ask: 850.40
Change: 0.00 (0.00%)
Spread: 0.40 (0.047%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 847.40
WPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Amended Form 20-F and 6-K

15 Feb 2021 07:00

RNS Number : 0157P
WPP PLC
15 February 2021
 

FOR IMMEDIATE RELEASE

15 February 2021

 

WPP PLC ("WPP")Amended Form 20-F and 6-K

WPP plc ("WPP" or the "Company") announces that, further to its announcement issued on 14 December 2020, it has filed a Form 20-F/A and furnished a Form 6-K/A with the US Securities and Exchange Commission (SEC), which are available at https://www.wpp.com/investors/shareholder-centre/sec-filings

The Form 20-F/A amends WPP plc's 2019 annual report on Form 20-F for the financial year ended 31 December 2019, originally filed with the SEC on 30 April 2020, and the Form 6-K/A amends WPP's interim report on Form 6-K for the period ended 30 June 2020, originally furnished with the SEC on 3 September 2020.

A copy of the above documents have been submitted to the National Storage Mechanism, where they will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism

For further information:

Investor Relations

Peregrine Riviere +44 (0)7909 907193

Buchanan CommunicationsRichard Oldworth +44 (0)20 7466 5000 / +44 (0)7710 130 634

Forward looking statements

This announcement includes statements and information that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). Forward-looking statements include all statements that are not historical facts and can be identified by terms such as "anticipates", "believes", "could", "estimates", "expects", "intends", "may", "plans", "potential", "predicts", "projects", "should", "will", "would" or similar expressions. These forward-looking statements may include, among other things, statements regarding the Company's expectations with respect to the nature and amount of any identified errors in its prior financial statements and the steps the Company intends to take in response thereto. As such, actual results or outcomes may differ materially from those discussed in the forward-looking statements. Important factors that may cause actual results to differ include but are not limited to: the unanticipated loss of a material client or key personnel, delays or reductions in client advertising budgets, shifts in industry rates of compensation, regulatory compliance costs or litigation, natural disasters or acts of terrorism, the Company's exposure to changes in the values of major currencies other than the UK pound sterling (because a substantial portion of its revenues are derived and costs incurred outside of the United Kingdom) and the overall level of economic activity in the Company's major markets (which varies depending on, among other things, regional, national and international political and economic conditions and government regulations in the world's advertising markets). In addition, you should consider the risks described in Item 3D, captioned "Risk Factors", in the Company's Form 20-F/A for the year ended 31 December 2019 and any impacts of the COVID-19 pandemic which could also cause actual results to differ from forward-looking information. In light of these and other uncertainties, the forward-looking statements included in the oral or written public statements should not be regarded as a representation by the Company that the Company's plans and objectives will be achieved.

Other than in accordance with its legal or regulatory obligations (including under the Market Abuse Regulation, the UK Listing Rules and the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority), the Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. The reader should, however, consult any additional disclosures that the Company may make in any documents which it publishes and/or files with the U.S. Securities and Exchange Commission. All readers, wherever located, should take note of these disclosures. Accordingly, no assurance can be given that any particular expectation will be met and shareholders are cautioned not to place undue reliance on the forward-looking statements.

Any forward-looking statements made by or on behalf of the Group speak only as of the date they are made and are based upon the knowledge and information available to the Directors of the Company at that time.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURDKBBKFBKDDBD
Date   Source Headline
27th Mar 20233:00 pmRNSAcquisition
27th Mar 20232:41 pmRNSExecutive Performance Share Awards
24th Mar 20237:00 amRNSAnnual Report 2022 on Form 20-F
23rd Mar 20234:21 pmRNSAnnual Report 2022 and AGM Notice
23rd Mar 202311:15 amRNSBoard Change
22nd Mar 202312:46 pmRNSCFO Transition Update
22nd Mar 20237:00 amRNSAcquisition
17th Mar 202310:54 amRNSVesting of Executive Share Award
15th Mar 20232:44 pmRNSBoard and Committee membership changes
7th Mar 20237:00 amRNSAcquisition
1st Mar 20232:07 pmRNSTotal Voting Rights and Capital
27th Feb 202310:45 amRNSDirector / PDMR Transaction notification
23rd Feb 20237:00 amRNS2022 Preliminary Results
1st Feb 20231:04 pmRNSTotal Voting Rights and Capital
19th Jan 20233:47 pmRNSNotification of 2022 Preliminary Results
5th Jan 20232:00 pmRNSAcquisition
3rd Jan 20231:26 pmRNSTotal Voting Rights and Capital
8th Dec 202212:00 pmRNSAcquisition
1st Dec 20223:53 pmRNSTotal Voting Rights and Capital
24th Nov 20227:00 amRNSTransaction in Own Shares
23rd Nov 20227:00 amRNSTransaction in Own Shares
22nd Nov 20227:00 amRNSTransaction in Own Shares
21st Nov 20227:00 amRNSTransaction in Own Shares
18th Nov 20227:00 amRNSTransaction in Own Shares
17th Nov 20227:00 amRNSTransaction in Own Shares
16th Nov 20227:00 amRNSTransaction in Own Shares
15th Nov 20227:00 amRNSTransaction in Own Shares
14th Nov 20227:00 amRNSTransaction in Own Shares
11th Nov 20227:00 amRNSTransaction in Own Shares
10th Nov 20227:00 amRNSTransaction in Own Shares
9th Nov 20227:00 amRNSTransaction in Own Shares
8th Nov 20227:00 amRNSWPP ANNOUNCES CFO TRANSITION
7th Nov 20223:47 pmRNSNotification of Major Holdings
4th Nov 20227:00 amRNSTransaction in Own Shares
3rd Nov 20227:00 amRNSTransaction in Own Shares
2nd Nov 20227:00 amRNSTransaction in Own Shares
1st Nov 20221:19 pmRNSTotal Voting Rights and Capital
1st Nov 20227:00 amRNSTransaction in Own Shares
31st Oct 20227:00 amRNSTransaction in Own Shares
28th Oct 20227:00 amRNSTransaction in Own Shares
27th Oct 20227:00 amRNSTransaction in Own Shares
26th Oct 20227:00 amRNSThird Quarter Trading Update
6th Oct 20221:30 pmRNSAcquisition
5th Oct 20229:00 amRNSNotification of Trading Update
3rd Oct 202211:24 amRNSTotal Voting Rights and Capital
26th Sep 20227:00 amRNSTransaction in Own Shares
23rd Sep 20227:00 amRNSTransaction in Own Shares
23rd Sep 20227:00 amRNSTransaction in Own Shares
22nd Sep 20227:00 amRNSTransaction in Own Shares
21st Sep 20222:15 pmRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.